Position in CPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$11,156,360
+$4,336,226 QoQ
Shares Held
450,580
+54.2% QoQ
Ownership
0.368%
of shares outstanding
% of Portfolio
1.72%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GLOBEFLEX CAPITAL L P holds $38,255,818 across 17 Biotechnology names. CPRX ranks #2 (29.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
260,706 | $11,181,680 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
450,580 | $11,156,360 | |
| 3 | RIGL |
Rigel Pharmaceuticals Inc
|
217,839 | $5,890,366 | |
| 4 | PBYI |
Puma Biotechnology, Inc.
|
349,651 | $2,234,269 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
10,594 | $2,002,795 | |
| 6 | INCY |
Incyte Corp
|
15,643 | $1,472,319 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
214,350 | $846,682 | |
| 8 | BDTX |
Black Diamond Therapeutics, Inc.
|
305,276 | $650,237 |
All Filings in CPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,156,360 | 450,580 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,820,134 | 292,208 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,726,376 | 290,679 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,468,487 | 298,087 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,164,010 | 254,186 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,065,183 | 194,786 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $922,392 | 46,398 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,543,864 | 228,784 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,646,816 | 228,784 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,845,859 | 228,784 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,738,779 | 234,284 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,984,906 | 296,496 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,043,486 | 304,191 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,658,771 | 304,235 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,904,079 | 304,293 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,134,650 | 304,515 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,524,429 | 304,515 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,061,566 | 304,515 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,613,929 | 304,515 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,513,865 | 611,107 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,814,363 | 610,491 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,256,531 | 376,207 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||